99% Savings - Buy Just @1 Rs X
Cetirizine + Pseudoephedrine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Cetirizine + Pseudoephedrine safe for pregnant women?
Cetirizine + Pseudoephedrine can have harmful effects in pregnant women. If you experience any discomfort after using Cetirizine + Pseudoephedrine, then discontinue the use and take your doctor's advice.
Is the use of Cetirizine + Pseudoephedrine safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Cetirizine + Pseudoephedrine. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Cetirizine + Pseudoephedrine on the Kidneys?
Cetirizine + Pseudoephedrine rarely affects the kidneys.
What is the effect of Cetirizine + Pseudoephedrine on the Liver?
Cetirizine + Pseudoephedrine is completely safe for the liver.
What is the effect of Cetirizine + Pseudoephedrine on the Heart?
Side effects of Cetirizine + Pseudoephedrine rarely affect the heart.
Cetirizine + Pseudoephedrine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Cetirizine + Pseudoephedrine unless your doctor advises you to do so -
Is this Cetirizine + Pseudoephedrine habit forming or addictive?
Cetirizine + Pseudoephedrine does not cause addiction.
Interaction between Food and Cetirizine + Pseudoephedrine
Taking Cetirizine + Pseudoephedrine with food does not harm your health.
Interaction between Alcohol and Cetirizine + Pseudoephedrine
No research has been done on this till date. Therefore, it is not known what the effect of taking Cetirizine + Pseudoephedrine with alcohol will be.
Discontinuation of Cetirizine + Pseudoephedrine on your own can cause unwanted side effects and withdrawal symptoms. You are recommended to always consult a doctor before discontinuing this medicine.
Cetirizine + Pseudoephedrine is not a pain-killer. It belongs to the class of drug called antihistamine. Which can help in relieving symptoms of allergies, runny nose, sneezing, and red-watery itchy eyes.
Cetirizine + Pseudoephedrine is a brand name of Cetirizine. It is a prescription drug that belongs to the class of medications called antihistamine (H1 receptor blocker). It is used in the treatment of allergic rhinitis, urticaria, runny nose, itching eyes/nose, sneezing and other types of allergies.
Cetirizine + Pseudoephedrine is a prescription drug so do not take it without consulting a doctor. It can be harmful for the patient to take this medicine without a doctor's recommendation.
Although, Cetirizine + Pseudoephedrine is classified as a non-drowsy antihistamine, but it can still cause drowsiness in some people. If you are taking this drug and feeling drowsy, then you are recommended not to drive or use heavy machinery. Please consult your doctor if you experience any unwanted side- effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 166-167
April Hazard Vallerand, Cynthia A. Sanoski. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 316-317
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZYRTEC® (cetirizine hydrochloride) Tablets and Syrup For Oral Use
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136-137
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1065-1066